Capital Cardiology Associates

Troy, New York 12180

0 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Cardiovascular Disease, Combined Hyperlipidemia, Coronary Artery Disease, Diastolic Heart Failure, High Cardiovascular Risk, Myocardial Infarction, Obesity, Overweight, Percutaneous Coronary Intervention, Type 2 Diabetes

Studies at this site

• A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia — Completed
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early